Phase 4
N=20
Esophageal Food Impaction
Esophageal Food Bolus Obstruction
Bottom Line
View on ClinicalTrials.gov: NCT03305848 ↗Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Feb 2023
Primary outcome: Primary: Patients Condition at Discharge — 2; 15 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Nitrostat 0.4Mg Sublingual Tablet (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- HealthPartners Institute
- Primary completion
- Apr 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patients Condition at Discharge |
2; 15 | — |
| PRIMARY Medications/Procedures Performed During Visit |
7; 15 | — |
Summary
This study is designed to obtain data on the safety and efficacy of oral nitroglycerin solution for the treatment of esophageal food impaction in patients presenting to the Emergency Department with presumed esophageal food impaction. The main hypothesis is to determine the success rate of oral nitroglycerin solution in relieving the food impaction by assessing the resolution of symptoms and the ability of the patient to swallow.
Eligibility Criteria
Inclusion Criteria
- Over the age of 18 years
- Presentation consistent with esophageal food impaction
- Ability to swallow a small volume of liquid.
Exclusion Criteria
- Intractable vomiting
- Hemodynamic instability or SBP 12 hours since onset.
Data sourced from ClinicalTrials.gov (NCT03305848). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.